MINGYANG TECHNOLOGY
837663
Shanghai Weihong Electronic Technology
300508
Shenzhen Intellifusion Technologies
688343
4
Est Tools Co., Ltd.
300488
5
Jiangyin Pivot Automotive Products
301181
US Stock MarketDetailed Quotes
KAPA Kairos Pharma
- 1.140
- -0.050-4.20%
Close Feb 25 16:00 ET
- 1.170
- +0.030+2.63%
Post 19:47 ET
15.62MMarket Cap-5.43P/E (TTM)
1.250High1.140Low133.84KVolume1.160Open1.190Pre Close158.27KTurnover8.64%Turnover RatioLossP/E (Static)13.70MShares4.00052wk High4.69P/B1.77MFloat Cap0.85152wk Low--Dividend TTM1.55MShs Float4.000Historical High--Div YieldTTM9.24%Amplitude0.851Historical Low1.182Avg Price1Lot Size
Trending Stocks
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!
Kairos Pharma Stock Forum
Major Clinical Trial Update: KAPA's Prostate Cancer Drug Gets Prestigious Cancer Center Backing
Groundbreaking Cancer Drug KROS101 Outperforms Existing Treatment in Melanoma Studies
Kairos Pharma Oral Presentation on Its Investigational Compound KROS 101 at the 13th AACR-JCA Joint Conference Supports the Compound's Potential as a Therapeutic for Melanoma and Glioblastoma
Thursday, 6th February at 8:30 am
Kairos Pharma, Ltd. (NYSE: KAPA), a clinical-stage biopharmaceutical company, announces that the Company presented a talk during the plenary session of the joint AACR-JCA conference, From Cancer Discovery Science to Therapeutic Innovation, highl...
beautiful pump in
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you do...
No comment yet